Page 1 - 2 Director Reports (Annexure) 2021.cdr

44-45

ANNEXURE 'B'
ANNEXURE 'A’ DETAILS OF REMUNERATION PURSUANT TO SECTION 134(3)(q)
FORM AOC - 1: STATEMENT CONTAINING SALIENT FEATURES OF THE FINANCIAL AND SECTION 197(12) OF THE ACT READ WITH RULE 5(1) OF THE
STATEMENTS OF SUBSIDIARIES/ ASSOCIATE COMPANIES/JOINT VENTURES COMPANIES (APPOINTMENT AND REMUNERATION OF
(Pursuant to first proviso to Sub-Section (3) of Section 129 of the Act read with Rule 5 of Companies (Accounts) Rules, MANAGERIAL PERSONNEL) RULES, 2014
2014)
A. Ratio of the remuneration of each Director to the Median remuneration of the employees of the Company;
PART A: SUBSIDIARIES (` in Lakhs) Name of the Director Designation Ratio of Remuneration to Median
Name of the Subsidiary Company Dr. Morepen Limited* Total Care Limited# Morepen Inc. Remuneration of Employees
Mr. Sushil Suri Chairman & Managing Director 169.35
Reporting period for the subsidiary 01-04-2020 to 01-04-2020 to 01-04-2020 to
concerned, if different from the 31-03-2021 31-03-2021 31-03-2021 Mr. Sanjay Suri Whole-time Director 119.40
holding company's reporting period Dr. A.K. Sinha Whole-time Director 2.83
`
Reporting currency and Exchange - - US$/ 73.53 Ms. Anju Suri Non-Executive Director -
rate as on the last date of the (As on 31.03.2021) Mr. B. R. Wadhwa* Independent Director 0.93
relevant Financial year in the case
Mr. Sukhcharan Singh* Independent Director 0.79
of foreign subsidiaries
Mr. Manoj Joshi* Independent Director 1.05
Share Capital 4,067.95 933.39 22.23
Mr. P.K.Dutt* Independent Director 0.55
(4,06,79,500 Equity (9,33,390 Equity (9,400 Fully paid
Shares of `10/- each) Shares of `100/- each) shares of US$1 each) Dr. Savita* Independent Director 0.47
Reserves & Surplus 464.55 (1,851.87) 223.61 Percentage increase in remuneration of each Director, Chief Financial Officer and Company Secretary in the
financial year;
Total Assets 7107.77 16.63 315.13
Total Liabilities 7107.77 16.63 315.13 Name of the Director/KMP Designation % increase of remuneration
in F.Y. 2020-21
Investments 1171.00 - -
Mr. Sushil Suri Chairman & Managing Director 214.98
Turnover 8594.11 12.00 181.89
Mr. Sanjay Suri Whole-time Director 470.82**
Profit/(Loss) before taxation 363.27 8.29 54.75
Dr. A. K. Sinha Whole-time Director -
Provision for taxation 136.12 - 6.03
Ms. Anju Suri Non-Executive Director -
Profit after taxation 227.15 8.29 48.72
Mr. B. R. Wadhwa* Independent Director (3.28)
Proposed Dividend - - -
Mr. Sukhcharan Singh* Independent Director (10.71)
Percentage of Shareholding 100%* 95% 100% Mr. Manoj Joshi* Independent Director (2.90)
* During the year 1,01,69,875 nos. of warrants, at an issue price of `30/- (Rupees Thirty Only) per warrant, were Mr. P. K. Dutt* Independent Director 133.33
allotted to two entities namely Blue Heaven Marketing Private Limited and Vignet Trading Private Limited
entitling equivalent number of Equity Shares of `10/- per share. Dr. Savita* Independent Director -
Mr. Ajay Kumar Sharma Chief Financial Ofcer 5.98
# Subsidiary of Dr. Morepen Limited.
Mr. Vipul Kumar Srivastava Company Secretary 27.75
PART B: ASSOCIATES & JOINT VENTURES - N.A.
* These Directors of the Company are paid sitting fees only.
For and on behalf of Board of Directors ** Annualized increase
B. The percentage increase in the median remuneration of employees in the Financial Year 2020-21 was 12.29%.
C. The number of permanent employees on the rolls of the Company as on March 31, 2021, was 1510.
D. The average percentile increases in the salaries of the employees other than the managerial personnel in the
Sushil Suri
Financial Year 2020-21 was 17.94% while increase in Managerial remuneration was 200.08%.
Place: New Delhi (Chairman & Managing Director)
E. It is hereby affirmed that the remuneration is as per Remuneration Policy of the Company.
th
Date: 27 July DIN: 00012028
, 202 1
For and on behalf of Board of Directors
Sushil Suri
Place: New Delhi (Chairman & Managing Director)
th
Date: 27 July, 2021 DIN: 00012028